← back to search

Emmanuelle Waubant

University of California, San Francisco · US
Area of research
Pathology and Forensic Medicine · Neurology
Research interest
Research interests include Multiple Sclerosis Research Studies, Peripheral Neuropathies and Disorders, Systemic Lupus Erythematosus Research, and Viral Infections and Immunology Research.
h-index
81
citations
46,875
works
498
NIH funding
primary concept
email

Recent publications

Epigenetic Aging in Pediatric-Onset Multiple Sclerosis
Neurology 2025cited by 7position: middledoi
Study of the Association Between Menarche and Disease Course in Pediatric Multiple Sclerosis
Neurology 2025cited by 3position: middledoi
MOG CNS Autoimmunity and MOGAD
Neurology Neuroimmunology & Neuroinflammation 2024cited by 51position: middledoi
Predictors of a relapsing course in myelin oligodendrocyte glycoprotein antibody-associated disease
Journal of Neurology Neurosurgery & Psychiatry 2024cited by 25position: lastdoi
Synaptic injury in the inner plexiform layer of the retina is associated with progression in multiple sclerosis
Cell Reports Medicine 2024cited by 23position: middledoi
Mediterranean diet and associations with the gut microbiota and pediatric-onset multiple sclerosis using trivariate analysis
Communications Medicine 2024cited by 15position: middledoi
Gene–environment interactions: Epstein–Barr virus infection and risk of pediatric-onset multiple sclerosis
Multiple Sclerosis Journal 2024cited by 8position: lastdoi
Increased intraindividual variability (IIV) in reaction time is the earliest indicator of cognitive change in MS: A two-year observational study
International Journal of Clinical and Health Psychology 2024cited by 4position: middledoi
Differential diagnosis of suspected multiple sclerosis: an updated consensus approach
The Lancet Neurology 2023cited by 140position: middledoi
Serum neurofilament light chain reference database for individual application in paediatric care: a retrospective modelling and validation study
The Lancet Neurology 2023cited by 52position: middledoi
High-dose vitamin D3 supplementation in relapsing-remitting multiple sclerosis: a randomised clinical trial
EClinicalMedicine 2023cited by 47position: middledoi
Susceptibility-based imaging aids accurate distinction of pediatric-onset MS from myelin oligodendrocyte glycoprotein antibody-associated disease
Multiple Sclerosis Journal 2023cited by 30position: lastdoi
Demographic Features and Clinical Course of Patients With Pediatric-Onset Multiple Sclerosis on Newer Disease-Modifying Treatments
Pediatric Neurology 2023cited by 21position: lastdoi
Gene–environment interactions increase the risk of paediatric-onset multiple sclerosis associated with household chemical exposures
Journal of Neurology Neurosurgery & Psychiatry 2023cited by 15position: lastdoi
Silent findings: Examination of asymptomatic demyelination in a pediatric US cohort
Multiple Sclerosis and Related Disorders 2023cited by 4position: middledoi
Proportionality-based association metrics in count compositional data
bioRxiv (Cold Spring Harbor Laboratory) 2023cited by 0position: middledoi
<scp>MOG</scp>and<scp>AQP4</scp>Antibodies among Children with Multiple Sclerosis and Controls
Annals of Neurology 2022cited by 33position: middledoi
A new look at cognitive functioning in pediatric MS
Multiple Sclerosis Journal 2022cited by 16position: middledoi
Gene–environment interactions increase the risk of pediatric-onset multiple sclerosis associated with ozone pollution
Multiple Sclerosis Journal 2022cited by 13position: lastdoi
Therapeutic Response in Pediatric Neuromyelitis Optica Spectrum Disorder
Neurology 2022cited by 12position: middledoi
A phase I study of oral vitamin D3 in boys with X-linked adrenoleukodystrophy
medRxiv 2022cited by 1position: middledoi
Myelin-oligodendrocyte glycoprotein antibody-associated disease
The Lancet Neurology 2021cited by 510position: middledoi
Spinal Cord Atrophy Predicts Progressive Disease in Relapsing Multiple Sclerosis
Annals of Neurology 2021cited by 115position: middledoi
Multi-omic evaluation of metabolic alterations in multiple sclerosis identifies shifts in aromatic amino acid metabolism
Cell Reports Medicine 2021cited by 85position: middledoi
The gut microbiota in pediatric multiple sclerosis and demyelinating syndromes
Annals of Clinical and Translational Neurology 2021cited by 67position: lastdoi
Central vein sign: A diagnostic biomarker in multiple sclerosis (CAVS-MS) study protocol for a prospective multicenter trial
NeuroImage Clinical 2021cited by 59position: middledoi
Gut microbiome is associated with multiple sclerosis activity in children
Annals of Clinical and Translational Neurology 2021cited by 41position: lastdoi
Etiological research in pediatric multiple sclerosis: A tool to assess environmental exposures (PEDiatric Italian Genetic and enviRonment ExposurE Questionnaire)
Multiple Sclerosis Journal - Experimental Translational and Clinical 2021cited by 3position: middledoi
Etiological research in pediatric multiple sclerosis: A tool to assess environmental exposures (PEQ-IT)
Journal of the Neurological Sciences 2021cited by 0position: middledoi
Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammation
Journal of Clinical Investigation 2020cited by 221position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jennifer Graves · Drexel University30 papers (2014–2025)Lauren Krupp · NYU Langone Health23 papers (2012–2024)Tanuja Chitnis · Harvard University21 papers (2012–2025)Bianca Weinstock‐Guttman · ECD for the Masses (United States)19 papers (2012–2025)Mark Gorman · Brigham and Women's Hospital19 papers (2012–2025)Jayne Ness · University of Alabama at Birmingham18 papers (2012–2025)Moses Rodriguez · Mayo Clinic17 papers (2012–2025)Soe Mar · Washington University in St. Louis15 papers (2016–2025)T. Charles Casper · University of Utah15 papers (2016–2025)Teri Schreiner · University of Colorado Anschutz Medical Campus14 papers (2016–2025)John Rose · University of Utah14 papers (2016–2023)Bardia Nourbakhsh · Johns Hopkins University13 papers (2015–2021)Mary Rensel · Cleveland Clinic12 papers (2018–2025)Anita Belman · NYU Langone Health12 papers (2012–2025)Michael Waltz · University of Utah12 papers (2017–2025)Jan‐Mendelt Tillema · Mayo Clinic11 papers (2016–2023)Janace Hart · University of California, San Francisco11 papers (2016–2024)Ellen M. Mowry · Johns Hopkins University11 papers (2012–2023)Gregory Aaen · Loma Linda University10 papers (2016–2025)Timothy Lotze · Baylor College of Medicine10 papers (2016–2023)